Paper225192
Effect of sodium butyrate in combination with X-irradiation, chemotherapeutic and cyclic AMP stimulating agents on neuroblastoma cells in culture.
Prasad KN. Experientia, 1979. Cited by 8 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Effect of sodium butyrate in combination with X-irradiation, chemotherapeutic and cyclic AMP stimulating agents on neuroblastoma cells in culture. Papers, record 225192. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/225192
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Effect of sodium butyrate in combination with X-irradiation, chemotherapeutic and cyclic AMP stimulating agents on neuroblastoma cells in culture.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Butyrates | Major topic |
| Cyclic AMP | Major topic |
| Neuroblastoma | Major topic |
| Radiation Effects | Major topic |
| 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone | |
| Animals | |
| Cell Line | |
| Mice | |
| Papaverine | |
| Prostaglandins E | |
| Theophylline |
Source PubMed
References14
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 215,447 | Effect of sodium butyrate in combination with prostaglandin E1 and inhibitors of cyclic nucleotide phosphodiesterase on human amelanotic melanoma cells in culture. | Experientia | 1978 | https://conductscience.org/library/papers/215447 | PubMed |
| 2 | 172,521 | Regulation of growth and morphological modulation of HeLa65 cells in monolayer culture by dibutyryl cyclic AMP, butyrate and their analogs. | J Cell Physiol | 1975 | https://conductscience.org/library/papers/172521 | PubMed |
| 3 | 4,022 | Butyrate-induced glycolipid biosynthesis in HeLa cells: properties of the induced sialyltransferase. | Arch Biochem Biophys | 1976 | https://conductscience.org/library/papers/4022 | PubMed |
| 4 | 13,859,817 | Energy pathways of hepatoma No. 5123. | Nature | 1961 | https://conductscience.org/library/papers/13859817 | PubMed |
| 5 | 5,061,307 | Effect of DL-glyceraldehyde on mouse neuroblastoma cells in culture. | Cancer Res | 1972 | https://conductscience.org/library/papers/5061307 | PubMed |
| 6 | 4,944,191 | X-ray-induced morphological differentiation of mouse neuroblastoma cells in vitro. | Nature | 1971 | https://conductscience.org/library/papers/4944191 | PubMed |
| 8 | 4,144,665 | Basal level of neurotransmitter synthesizing enzymes and effect of cyclic AMP agents on the morphological differentiation of isolated neuroblastoma clones. | Nat New Biol | 1973 | https://conductscience.org/library/papers/4144665 | PubMed |
| 9 | 14,342,295 | THE ROLE OF GLYCOLYSIS IN THE GROWTH OF TUMOR CELLS. 3. LACTIC DEHYDROGENASE AS THE SITE OF ACTION OF OXAMATE ON THE GROWTH OF CULTURED CELLS. | J Biol Chem | 1965 | https://conductscience.org/library/papers/14342295 | PubMed |
| 10 | 5,743,708 | Arrest of cancer in mice by therapy with normal metabolites. II. Indefinite survirors among mice treated with mixtures of 2-oxopropanal (NSC-79019) and 2,3-dihydroxypropanal (NSC67934). | Cancer Chemother Rep | 1968 | https://conductscience.org/library/papers/5743708 | PubMed |
| 11 | 4,248,128 | Effects of elevated temperatures and drugs on the viability of L1210 leukemia cells. | Cancer Res | 1970 | https://conductscience.org/library/papers/4248128 | PubMed |
| 12 | 240,451 | Differentiation of neuroblastoma cells in culture. | Biol Rev Camb Philos Soc | 1975 | https://conductscience.org/library/papers/240451 | PubMed |
| 13 | 1,056,809 | Butyric acid, a potent inducer of erythroid differentiation in cultured erythroleukemic cells. | Cell | 1975 | https://conductscience.org/library/papers/1056809 | PubMed |
| 15 | 14,441,826 | Chemotherapy of sarcoma 180 by combinations of DL-glyceraldehyde with 6-thioguanine or with azaserine and 6-chloro-purine. | Proc Soc Exp Biol Med | 1960 | https://conductscience.org/library/papers/14441826 | PubMed |
| 16 | 4,107,316 | Morphologic differentiation of mouse neuroblastoma cells induced in vitro by dibutyryl adenosine 3':5'-cyclic monophosphate. | Nat New Biol | 1971 | https://conductscience.org/library/papers/4107316 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 2,886,147 | Biochemical and ultrastructural alterations accompany the anti-proliferative effect of butyrate on melanoma cells. | Br J Cancer | 1987 | https://conductscience.org/library/papers/2886147 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/225192
GET https://conductscience.org/api/papers/v1/225192/authors